OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target) (OX40/3108), CF647 conjugate, 0.1mg/mL

Catalog number BNC473108-500

Price for BNC473108-500

Size / count 1x 500 µL

About this product

ThisMAb recognizes a protein of 43 kDa, identified as OX40, which is also known as CD134. OX40 is a type I integral membrane glycoprotein and member of the tumor necrosis factor/nerve growth factor receptor (TNFR/NGFR) family. It is expressed on activated T lymphocytes, hematopoietic precursor cells and fibroblasts. It functions as a T cell co-stimulatory receptor when bound by OX40 Ligand/TNFSF4 that is expressed by antigen presenting cells. OX40 thereby plays roles in T-cell activation as well as the regulation of differentiation, proliferation or apoptosis of normal and malignant lymphoid cells. OX40 is upregulated at the sites of inflammation, especially in case of multiple sclerosis and psoriatic lesions. Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

Specifications

Catalog number: BNC473108-500
Size / count: 1x 500 µL
Dry ice: No
Hazardous: No
Discontinued: No
CAS Number: 9007-83-4
Synonyms: ACT35; CD134; Lymphoid activation antigen ACT35; OX40; TAX transcriptionally-activated glycoprotein 1 receptor; TNFRSF4 (Tumor necrosis factor receptor superfamily member 4)
UNSPSC: 41116161
UNSPSC Description: Primary and secondary antibodies for multiple methodology immunostaining detection application
Gene Name: TNFRSF4
Gene ID: 7293
NCBI Gene ID: 129780
UniProt: P43489
Swiss Prot: P43489
Host: Mouse
Species Reactivity: Chimpanzee, Human
Reactivity: CD134, |OX40|TNFRSF4
Immunogen: Recombinant fragment of human OX40 (CD134) protein (around aa 59-205) (exact sequence is proprietary)
Target Antigen: CD134, | OX40 | TNFRSF4
Clonality: Monoclonal
Clone: OX40/3108
Type: Primary
Source: Animal
Origin: Animal
Applications: Flow (verified) |IF (verified) |IHC, FFPE (verified)
Positive Control: MOLT-4 cells. Human peripheral blood leukocytes (hPBL). Human tonsil tissue (IHC).
Stability: 2 years
Concentration: 0.1 mg/mL
Buffer: PBS, 0.1% BSA, 0.05% azide
Molecular Weight: 43 kDa
Shipping Conditions: RT (ND)
Storage Conditions: Stable at room temperature or 37°C (98°F) for 7 days.
Notes: Protect from light
Shelf Life: Guaranteed for at least 24 months from date of receipt when stored as recommended
Fragment: IgG2c, kappa
Classification: 0.05% sodium azide (CAS 26628-22-8)
Conjugate: CF647

Frequently Asked Questions

What is the catalog number for OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target) (OX40/3108), CF647 conjugate, 0.1mg/mL?

The catalog number for OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target) (OX40/3108), CF647 conjugate, 0.1mg/mL is BNC473108-500.

What sizes are available for OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target) (OX40/3108), CF647 conjugate, 0.1mg/mL?

OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target) (OX40/3108), CF647 conjugate, 0.1mg/mL is available in the following size(s): 1x 500 µL.

Is OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target) (OX40/3108), CF647 conjugate, 0.1mg/mL in stock?

OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target) (OX40/3108), CF647 conjugate, 0.1mg/mL is currently made to order / not held in immediate stock. Contact us for lead time.

Who manufactures OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target) (OX40/3108), CF647 conjugate, 0.1mg/mL?

OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target) (OX40/3108), CF647 conjugate, 0.1mg/mL is manufactured by Biotium.

What is the estimated delivery time for OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target) (OX40/3108), CF647 conjugate, 0.1mg/mL?

Estimated delivery time for OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target) (OX40/3108), CF647 conjugate, 0.1mg/mL is approximately 15 business day(s), depending on your location.

Where can I find the safety data sheet (SDS/MSDS) for OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target) (OX40/3108), CF647 conjugate, 0.1mg/mL?

The safety data sheet for OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target) (OX40/3108), CF647 conjugate, 0.1mg/mL is available here: https://cdn.gentaur.com/products/37/68dd029e061270361e102f1d/msds/bnc473108-500.pdf.

What is OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target) (OX40/3108), CF647 conjugate, 0.1mg/mL used for?

What dilution range is recommended for immunohistochemistry (IHC) with this antibody?

A starting IHC dilution range is listed on the datasheet, but should be optimized for your specific tissue type and staining protocol.

Can I request a Safety Data Sheet (SDS) for this product?

Yes, safety data sheets are available for hazardous or chemically classified products and can be provided on request or downloaded from the product page.

Can this product be used for co-immunoprecipitation (Co-IP)?

Suitability for Co-IP depends on the specific antibody and is noted under validated applications on the datasheet. If it isn’t listed, contact our technical support team for guidance based on your target and sample type.